Nasdaq
CTOR
Citius Oncology, Inc.
- Health Care
- Listed 2022
- 1 day
- −3.2%
- 1 month
- +7.0%
- 1 year
- −60.2%
$0.7600 · Mkt cap $70.7M
At the 6 Aug 2026 close
Nasdaq
Citius Oncology, Inc.
$0.7600 · Mkt cap $70.7M
At the 6 Aug 2026 close
Citius Oncology, Inc. trades under the ticker CTOR on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2022. Its market capitalisation is $70.7M. The last closing price was $0.7600, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −60.2%, and +7.0% over the past month. Returns are price returns and exclude dividends.
This page exists because CTOR is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.